Related Experiment Video
Updated: Jun 24, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
[Community-acquired Pseudomonas stutzeri meningitis in an immunocompetent patient]
Mustafa Sünbül1, Muammer Zivalioğlu, Nuriye Taşdelen Fişgin
1Ondokuz Mayis Universitesi Tip Fakültesi, Enfeksiyon Hastaliklari ve Klinik Mikrobiyoloji Anabilim Dali, Samsun. msunbul@omu.edu.tr
Abstract:
Pseudomonas stutzeri which is an aerobic, non-fermentative gram-negative bacillus frequently found in soil, water and hospital environment, rarely leads to serious community-acquired infections. In this report a case of community-acquired meningitis due to P. stutzeri was presented. A 73-years-old male patient was admitted to the emergency department with the complaints of nausea, vomiting, headache, dizziness, difficulties in walking and speaking and loss of consciousness. There was no history of an underlying disease or immunosuppression. Physical examination revealed nuchal rigidity, however, Kernig and Brudzinski signs were negative. The cerebrospinal fluid (CSF) analysis revealed 0.4 mg/dl glucose (simultaneous blood glucose 145 mg/dl), and 618 mg/dl protein and 640 leucocyte/mm3 (90% PMNL). No bacteria were detected in Gram stained and Ehrlich-Ziehl-Neelsen stained CSF smears. Upon the diagnosis of acute bacterial meningitis, treatment with ceftriaxone and ampicillin was initiated, however, the patient died after 16 hours of hospitalization. CSF culture yielded the growth of gram-negative oxidase-positive bacteria and the isolate was identified as P. stutzeri by Vitek-2 Compact system (bioMerieux, France). The isolate was found to be sensitive to piperacillin/tazobactam, amikacin, gentamycin, ceftazidime, cefepime, ciprofloxacin, imipenem and meropenem. Since the patient was lost due to acute respiratory and cardiac failure, it was not possible to change the therapy to agent specific therapy. In conclusion, it should always be kept in mind that uncommon agents could lead to community-acquired meningitis in elderly patients and empirical treatment protocols might fail in such cases resulting in high morbidity and mortality.
Insights
A rare case of community-acquired bacterial meningitis caused by Pseudomonas stutzeri in an elderly male highlights the potential for uncommon pathogens to cause severe infections. Empirical treatment may fail, underscoring the need for vigilance in diagnosing unusual meningitis cases.
Area of Science:
- Microbiology
- Infectious Diseases
- Neurology
Background:
- Pseudomonas stutzeri is an aerobic, gram-negative bacillus commonly found in environmental settings.
- This bacterium rarely causes serious community-acquired infections, including meningitis.
Observation:
- A 73-year-old male presented with symptoms of acute bacterial meningitis, including altered mental status and nuchal rigidity.
- Cerebrospinal fluid analysis revealed low glucose, high protein, and a significant white blood cell count with a predominance of neutrophils.
- Initial Gram stain of cerebrospinal fluid was negative for bacteria.
Findings:
- Despite empirical treatment with ceftriaxone and ampicillin, the patient expired 16 hours after admission.
- Cerebrospinal fluid culture identified the causative agent as Pseudomonas stutzeri.
- The isolated Pseudomonas stutzeri strain demonstrated susceptibility to a range of antibiotics, including piperacillin/tazobactam, aminoglycosides, cephalosporins, carbapenems, and fluoroquinolones.
Implications:
- This case underscores that uncommon bacteria like Pseudomonas stutzeri can cause severe community-acquired meningitis, particularly in elderly individuals.
- Empirical treatment strategies for bacterial meningitis may be inadequate against rare pathogens, potentially leading to high morbidity and mortality.
- Clinicians should consider a broader spectrum of potential pathogens when managing meningitis in vulnerable populations, especially when initial diagnostic tests are inconclusive.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia
Cryptococcal Meningitis
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Meningitis I: Introduction